Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

29OK

PanDDA deposition -- Crystal Structure of SARS-CoV-2 main protease covalently bound to KL_C172

This is a non-PDB format compatible entry.
Summary for 29OK
Entry DOI10.2210/pdb29ok/pdb
Group depositionPanDDA analysis group deposition (G_1002371)
Descriptor3C-like proteinase nsp5, DIMETHYL SULFOXIDE, CHLORIDE ION, ... (5 entities in total)
Functional Keywordsdiamond light source, fragment screening, pandda, xchemexplorer, hydrolase, inhibitor
Biological sourceSevere acute respiratory syndrome coronavirus 2
More
Total number of polymer chains2
Total formula weight69476.89
Authors
Primary citationKollar, L.,Mihalovits, L.M.,Bajusz, D.,Knez, D.,Simon, J.,Balcomb, B.H.,Fearon, D.,Gobec, S.,Keseru, G.M.
Fragment-Based Design of Targeted Covalent Inhibitors: The Scope and Limitation of Linking Approaches.
Chemmedchem, 21:e202501108-e202501108, 2026
Cited by
PubMed Abstract: Linking of fragments in neighboring binding sites is one of the optimization strategies in fragment-based drug discovery, where additive or even more substantial bioactivity improvements can be realized. However, such efforts present a considerable challenge when one fragment binds covalently to the target protein, as small modifications can influence the correct positioning of the covalent warhead toward the targeted nucleophilic residue. Here, we present a case study of fragment linking that yielded single-digit micromolar, covalent inhibitors of the SARS-CoV-2 main protease, starting from fragments that were inactive in the biochemical assay. Using structural information from a recent, high-throughput crystallographic fragment screen, we show that the success of fragment linking in the design of targeted covalent inhibitors is heavily impacted by several factors, including the warhead type, the labeling chemistry, and even subtle changes in the designed linker. Notably, we observe that induced fit effects might override the original fragment orientations in the linked molecule, highlighting the need for reliable structure verification, especially in consecutive rounds of fragment elaboration.
PubMed: 42174747
DOI: 10.1002/cmdc.202501108
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.93 Å)
Structure validation

255900

건을2026-07-01부터공개중

PDB statisticsPDBj update infoContact PDBjnumon